{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:02:02Z","timestamp":1766023322975,"version":"3.48.0"},"reference-count":27,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/zgyb9556","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T08:24:31Z","timestamp":1755073471000},"page":"5757-5765","source":"Crossref","is-referenced-by-count":0,"title":["Clinical analysis of hospital-acquired infections in patients with multiple myeloma: a study of 200 cases"],"prefix":"10.62347","volume":"17","author":[{"given":"Hece","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"101168","DOI":"10.1016\/j.blre.2024.101168","article-title":"Chromosomal defects in multiple myeloma","volume":"64","author":"SE","year":"2024","unstructured":"Clarke SE, Fuller KA and Erber WN. Chromosomal defects in multiple myeloma. Blood Rev 2024; 64: 101168.","journal-title":"Blood Rev"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-024-00188-w","article-title":"Multiple myeloma: signaling pathways and targeted therapy","volume":"5","author":"Lu","year":"2024","unstructured":"Lu Q, Yang D, Li H, Niu T and Tong A. Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed 2024; 5: 25.","journal-title":"Mol Biomed"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/NHH.0000000000001249","article-title":"Multiple myeloma","volume":"42","author":"Vrtis","year":"2024","unstructured":"Vrtis MC. Multiple myeloma. Home Healthc Now 2024; 42: 140-149.","journal-title":"Home Healthc Now"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1080\/16078454.2022.2112643","article-title":"Multiple myeloma in Latin America","volume":"27","author":"G&#xF3","year":"2022","unstructured":"Gómez-Almaguer D and de Moraes Hungria VT. Multiple myeloma in Latin America. Hematology 2022; 27: 928-931.","journal-title":"Hematology"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Abdallah N and Kumar SK. Up-front treatment of elderly (Age ≥75 Years) and frail patients with multiple myeloma. J Natl Compr Canc Netw 2024; 22: e247039.","DOI":"10.6004\/jnccn.2024.7039"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.clml.2021.07.013","article-title":"Special Considerations for supportive care and management of complications in elderly patients with multiple myeloma","volume":"21","author":"George","year":"2021","unstructured":"George LL, Malik MN, Miller EJ, Hicks K, Khanam R, Saterehaseman A, McNichol M and Anwer F. Special Considerations for supportive care and management of complications in elderly patients with multiple myeloma. Clin Lymphoma Myeloma Leuk 2021; 21: 812-822.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Goldschmidt H. Multiples myelom - bald heilbar? Multiple myeloma-soon curable? Internist (Berl) 2021; 62: 562-570.","DOI":"10.1007\/s00108-021-01010-3"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12885-021-08451-x","article-title":"Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019","volume":"21","author":"Balmaceda","year":"2021","unstructured":"Balmaceda N, Aziz M, Chandrasekar VT, McClune B, Kambhampati S, Shune L, Abdallah AO, Anwer F, Majeed A, Qazilbash M, Ganguly S, McGuirk J and Mohyuddin GR. Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019. BMC Cancer 2021; 21: 730.","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.clml.2024.05.002","article-title":"Risk of infection in patients with multiple myeloma treated with t-cell redirecting approaches: a call out for clinicians","volume":"24","author":"Lupia","year":"2024","unstructured":"Lupia T, Cani L, Bringhen S, De Rosa FG, Bruno B, Mikulska M, Corcione S and Mina R. Risk of infection in patients with multiple myeloma treated with t-cell redirecting approaches: a call out for clinicians. Clin Lymphoma Myeloma Leuk 2024; 24: 592-603.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol 2024; 99: 1802-1824.","journal-title":"Am J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00277-024-05730-y","article-title":"Therapeutic progress in relapsed\/refractory multiple myeloma","volume":"103","author":"Chen","year":"2024","unstructured":"Chen Q, Zhang M, Zheng S, Tong Y and Tan Y. Therapeutic progress in relapsed\/refractory multiple myeloma. Ann Hematol 2024; 103: 1833-1841.","journal-title":"Ann Hematol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"15142","DOI":"10.1038\/s41598-024-65937-x","article-title":"Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verification","volume":"14","author":"Sun","year":"2024","unstructured":"Sun C, Zhang W, Liu H, Ding Y, Guo J, Xiong S, Zhai Z and Hu W. Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verification. Sci Rep 2024; 14: 15142.","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12944-024-02289-5","article-title":"Lipid levels and multiple myeloma risk: insights from Meta-analysis and mendelian randomization","volume":"23","author":"Zhu","year":"2024","unstructured":"Zhu W, Charwudzi A, Li Q, Zhai Z, Hu L and Pu L. Lipid levels and multiple myeloma risk: insights from Meta-analysis and mendelian randomization. Lipids Health Dis 2024; 23: 299.","journal-title":"Lipids Health Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/medsci9010003","article-title":"Epidemiology, staging, and management of multiple myeloma","volume":"9","author":"Padala","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A, Rawla P, Vakiti A, Kolhe R, Kota V and Ajebo GH. Epidemiology, staging, and management of multiple myeloma. Med Sci (Basel) 2021; 9: 3.","journal-title":"Med Sci (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol 2016; 43: 676-681.","journal-title":"Semin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Elcarte E, Withers M and Wong MCS; Non-communicable Disease Global Health Research Group, Association of Pacific Rim Universities. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol 2022; 9: e670-e677.","DOI":"10.1016\/S2352-3026(22)00165-X"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.bja.2024.07.035","article-title":"Preoperative preparation of children with upper respiratory tract infection: a focussed narrative review","volume":"133","author":"Stepanovic","year":"2024","unstructured":"Stepanovic B, Regli A, Becke-Jakob K and von Ungern-Sternberg BS. Preoperative preparation of children with upper respiratory tract infection: a focussed narrative review. Br J Anaesth 2024; 133: 1212-1221.","journal-title":"Br J Anaesth"},{"key":"ref17","unstructured":"Sardeli AV, de Araujo RB, Woods JA, Lord JM and Chacon-Mikahil MPT. Higher risk of upper respiratory tract infection post marathon running: when physical exercise becomes a threat to the immune system. Exerc Immunol Rev 2024; 30: 6-13."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/10428194.2022.2138380","article-title":"Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma","volume":"64","author":"Bici","year":"2023","unstructured":"Bici A, Pianko MJ and Nachar VR. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Leuk Lymphoma 2023; 64: 407-414.","journal-title":"Leuk Lymphoma"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00520-021-06557-3","article-title":"Risk factors and characteristics of bacterial infection during first-line chemotherapy for metastatic gastric or gastroesophageal junction adenocarcinoma","volume":"30","author":"Jin","year":"2022","unstructured":"Jin X, Wu S and Bai Y. Risk factors and characteristics of bacterial infection during first-line chemotherapy for metastatic gastric or gastroesophageal junction adenocarcinoma. Support Care Cancer 2022; 30: 2121-2129.","journal-title":"Support Care Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2023.04.003","article-title":"Obesity and multiple myeloma: emerging mechanisms and perspectives","volume":"92","author":"Tentolouris","year":"2023","unstructured":"Tentolouris A, Ntanasis-Stathopoulos I and Terpos E. Obesity and multiple myeloma: emerging mechanisms and perspectives. Semin Cancer Biol 2023; 92: 45-60.","journal-title":"Semin Cancer Biol"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Tentolouris A, Ntanasis-Stathopoulos I, Eleftheriadou I, Malandrakis P, Tzeravini E and Gavriatopoulou M. Diabetes mellitus and multiple myeloma; common features of two distinct entities. Diabetes Metab Res Rev 2022; 38: e3535.","DOI":"10.1002\/dmrr.3535"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41408-022-00679-5","article-title":"High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions","volume":"12","author":"Hagen","year":"2022","unstructured":"Hagen P, Zhang J and Barton K. High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions. Blood Cancer J 2022; 12: 83.","journal-title":"Blood Cancer J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/ijlh.13958","article-title":"The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma","volume":"45","author":"Solmaz","year":"2023","unstructured":"Solmaz S, Uzun O, Sevindik OG, Demirkan F, Ozcan MA, Ozsan GH and Alacacıoglu I. The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma. Int J Lab Hematol 2023; 45: 13-19.","journal-title":"Int J Lab Hematol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3000605211038135","DOI":"10.1177\/03000605211038135","article-title":"Efficacy and safety of daratumumab in the treatment of multiple myeloma: a systematic review and meta-analysis","volume":"49","author":"Wang","year":"2021","unstructured":"Wang Y, Li Y and Chai Y. Efficacy and safety of daratumumab in the treatment of multiple myeloma: a systematic review and meta-analysis. J Int Med Res 2021; 49: 3000605211038135.","journal-title":"J Int Med Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1123029","DOI":"10.3389\/fonc.2023.1123029","article-title":"Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories","volume":"13","author":"Gkoliou","year":"2023","unstructured":"Gkoliou G, Agathangelidis A, Karakatsoulis G, Lalayanni C, Papalexandri A, Medina A, Genuardi E, Chlichlia K, Hatjiharissi E, Papaioannou M, Terpos E, Jimenez C, Sakellari I, Ferrero S, Ladetto M, Sanz RG, Belessi C and Stamatopoulos K. Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories. Front Oncol 2023; 13: 1123029.","journal-title":"Front Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41375-021-01180-x","article-title":"Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients","volume":"35","author":"Visram","year":"2021","unstructured":"Visram A, Vaxman I, S Al Saleh A, Parmar H, Dispenzieri A, Kapoor P, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Dingli D, Warsame R, Kourelis T, Siddiqui M, Gonsalves W, Muchtar E, Lust JA, Leung N, Kyle RA, Murray D, Rajkumar SV and Kumar S. Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients. Leukemia 2021; 35: 1428-1437.","journal-title":"Leukemia"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0166444.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:11Z","timestamp":1766023031000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0166444.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/zgyb9556","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}